Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
نویسندگان
چکیده
•A case of grade 2 endometrial adenocarcinoma in a young woman desiring fertility-sparing treatment•Successful conservative management of refractory endometrial adenocarcinoma with dual progestin therapy•A brief review of conservative management in endometrial adenocarcinoma.
منابع مشابه
Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility.
AIM To evaluate the outcome of a cohort of young women treated with progestin for fertility-sparing management of endometrial atypical hyperplasia (AH) and endometrial carcinoma (EC). This retrospective multicentre cohort study included women under the age of 40 years treated conservatively for AH and EC to preserve fertility using progestin for at least 3 months. Four inclusion criteria were d...
متن کاملFertility Sparing Treatment in Young Patients with Early Endometrial Adenocarcinoma: Case Series
OBJECTIVE The aim of this study was to evaluate fertility-sparing therapy in young patients with endometrial carcinoma. METHODOLOGY This prospective study was carried out on 8 patients with clinical and radio-graphic stage IA, well differentiated endometrioid adenocarcinoma of the endometrium in Alzahra hospital, Tabriz, Iran. Treatment comprised high-dose megestrol acetate. Dilatation and cu...
متن کاملO-29: Fertility Sparing Treatments in Young Patients with Gynecological Cancers: A Large Iranian Experience and A Literature Review
Background: The marriage age has been increasing recently throughout the world and researches have shown an increased rate of gynecological cancers among young women. Therefore, fertility sparing in these patients is an important point and many works have been done on conservative management in young women with gynecological cancer. Materials and Methods: In this study, we report our experience...
متن کاملProgestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Endometrial cancer is the most common gynecologic cancer in developed countries. Approximately 3%-14% of endometrial cancers are diagnosed in young women under 40 who want to preserve their fertility. The incidence of endometrial cancer in this age group is increasing, for which fertility-sparing therapy is increasingly used because it is one of the most important quality of life issues in thes...
متن کاملHysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword
The fertility-sparing management using progestin is now widely accepted as the alternative treatment for young women who eagerly want to preserve their fertility [1]. The selection of patients who will achieve complete response is the most important step for successful fertility-sparing management [1]. Patients with endometrium-confined, well-differentiated, endometrioid adenocarcinoma are the ...
متن کامل